EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Who uses Better Access treatment services? A re-analysis of data from the usual care arms of two randomised controlled trials

Meredith Harris iD, Caley Tapp iD, Long Khanh-Dao Le iD, Jan Faller iD, Bridget Bassilios iD, Philip Burgess iD, Mary Lou Chatterton iD, Patty Chondros iD, Katrina Scurrah iD, Matthew J Spittal iD, Cathrine Mihalopoulos iD, Jane Gunn iD und 1 weitere

Australian & New Zealand Journal of Psychiatry · 2026

DOI: 10.1177/00048674251406028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian & New Zealand Journal of Psychiatry, 2026. Verfasst von Meredith Harris und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, The University of Queensland, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Anxiety, Anxiety Disorders, Depression, Depressive Disorder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Australian Government Department of Health, Disability and Ageing, National Health and Medical Research Council, Department of Health, Disability and Ageing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe characteristics, service use and clinical changes among people who received treatment through Australia’s Better Access programme.

Methods

We re-analysed data from the usual care arms of two randomised controlled trials of tailored care approaches for depression and anxiety in primary care (Target-D, 2016–2019; Link-me, 2017–2019). Participants completed measures of depression and anxiety symptoms, quality of life and days out of role due to psychological distress over 12 months. They reported the use of mental health services from different providers/settings; from this, we classified a subset as likely Better Access treatment users.

Results

Of 394 Target-D and 547 Link-me participants, one-third were classified as having used Better Access treatment sessions over 12 months. They used five to seven Better Access sessions on average; half to two-thirds paid out-of-pocket costs (median $78–$89 per session). The number of Better Access sessions and other mental health services they used increased with severity of mental health problems. At baseline, Better Access treatment users reported more severe symptoms and more days out of role than those who used other or no mental health services, and poorer quality of life than those who used no services. Approximately half (43–55%) of Better Access treatment users showed improvements in mental health over 12 months. Among those with severe problems, improvements in depression and anxiety symptoms were associated with using 5+ Better Access sessions.

Conclusions

Better Access treatment is used by people with different levels of mental health need. Many experience improvements in their mental health and functioning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnxietyAnxiety DisordersDepressionDepressive DisorderHealth Services AccessibilityMental Health ServicesPatient Acceptance of Health CarePrimary Health CareAdultFemaleHumansMaleMiddle AgedAustraliaQuality of LifeRandomized Controlled Trials as TopicSecondary Data Analysis

Stichwörter der Autor:innen

Better Accessallied health professionalsanxietydepressionmental health servicesprimary carepsychological therapy

Autor:innen und Institutionen

  • School of Public Health, The University of Queensland, Brisbane, QLD, Australia.
  • Queensland Centre for Mental Health Research, Brisbane, QLD, Australia.
  • Health Economics Group, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Centre for Mental Health and Community Wellbeing, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
  • Department of General Practice, University of Melbourne, Melbourne, VIC, Australia.

ORCID-Profile: Meredith Harris, Caley Tapp, Long Khanh-Dao Le, Jan Faller, Bridget Bassilios, Philip Burgess, Mary Lou Chatterton, Patty Chondros, Katrina Scurrah, Matthew J Spittal, Cathrine Mihalopoulos, Jane Gunn, Jane Pirkis

Förderung

  • Australian Government Department of Health, Disability and Ageing
  • National Health and Medical Research Council
  • Department of Health, Disability and Ageing

Zitieren

APA

Harris, M., Tapp, C., Le, L. K., Faller, J., Bassilios, B., Burgess, P., Chatterton, M. L., Chondros, P., Scurrah, K., Spittal, M. J., Mihalopoulos, C., Gunn, J., & Pirkis, J. (2026). Who uses Better Access treatment services? A re-analysis of data from the usual care arms of two randomised controlled trials. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/00048674251406028

Vancouver

Harris M, Tapp C, Le LK, Faller J, Bassilios B, Burgess P, et al. Who uses Better Access treatment services? A re-analysis of data from the usual care arms of two randomised controlled trials. Australian & New Zealand Journal of Psychiatry. 2026. doi:10.1177/00048674251406028

BibTeX
@article{Harris2026,
  author = {Harris, Meredith and Tapp, Caley and Le, Long Khanh-Dao and Faller, Jan and Bassilios, Bridget and Burgess, Philip and Chatterton, Mary Lou and Chondros, Patty and Scurrah, Katrina and Spittal, Matthew J and Mihalopoulos, Cathrine and Gunn, Jane and Pirkis, Jane},
  title = {Who uses Better Access treatment services? A re-analysis of data from the usual care arms of two randomised controlled trials},
  journal = {Australian & New Zealand Journal of Psychiatry},
  year = {2026},
  doi = {10.1177/00048674251406028}
}
Kostenlos starten →